-
Lemtrada Use by MS Patient Linked to Bleeding in Lungs, 5 Cases Now Known Worldwide, Study Says
A potentially life-threatening case of bleeding in the lungs has been reported and attributed to treatment with Lemtrada (alemtuzumab) by a woman with relapsing-remitting multiple sclerosis. Read more about this story here.
This is the second story about Lemtrada and its potential risks on the forum this week. Do these stories make you wary of the drug?
Sorry, there were no replies found.
Log in to reply.